Targeting Features of Curaxin CBL0137 on Hematological Malignancies In Vitro and In Vivo.
Fetisov TI, Borunova AA, Antipova AS, Antoshina EE, Trukhanova LS, Gorkova TG, Zuevskaya SN, Maslov A, Gurova K, Gudkov A, Lesovaya EA, Belitsky GA, Yakubovskaya MG, Kirsanov KI.
Fetisov TI, et al. Among authors: antipova as.
Biomedicines. 2023 Jan 16;11(1):230. doi: 10.3390/biomedicines11010230.
Biomedicines. 2023.
PMID: 36672738
Free PMC article.